Dr Salem Chouaib completed his undergraduate studies at the university of Pierre and Marie Curie (Paris VI) at Pasteur Institute. He received his Doctorate es-sciences (Ph.D.) in immunology, (laboratory of Jean Dausset,) in 1983 from the same university. He then joined the Memorial Sloan Kettering Cancer Center in New York where he undertook a post-doctoral training in Human Immunogenetics Laboratory. In 1986, he was appointed as research associate at the French National Institute of Health and Biomedical Research (INSERM) and joined the tumor biology department at the Institut Gustave Roussy. In 1994 he became Research Director at INSERM and head of tumor immunology laboratory (INSERM U487) at Gustave Roussy.

Dr Chouaib’s research focuses on the investigation of the reactivity of killer cells in the context of tumor microenvironment complexity and plasticity. Dr Chouaib current research is focusing on the impact of tumor hypoxia on anti-tumor immune response regulation and acquisition of tumor resistant phenotype. His research was constantly directed at impulsing the transfer of fundamental concepts in clinical application in particular in the field of cancer immunotherapy. Recently, he created the Thumbay Research Institute for Precision Medicine at the Gulf Medical University .

Dr Chouaib’s research focuses on the investigation of the reactivity of killer cells in the context of tumor microenvironment complexity and plasticity. Dr Chouaib current research is focusing on the impact of tumor hypoxia on anti-tumor immune response regulation and acquisition of tumor resistant phenotype. His research was constantly directed at impulsing the transfer of fundamental concepts in clinical application in particular in the field of cancer immunotherapy. Recently, he created the Thumbay Research Institute for Precision Medicine at the Gulf Medical University .
Plus récemment, il a fondé le Thumbay Research Institute for Precision Medicine à Gulf Medical University.

He was awarded the cancer research prize of the French league against cancer in 1992 and in 2004 the presidential prize in biotechnology. He is a devoted educator having directed the work of many postdoctoral fellows.

. He is lecturing on cancer immunology for the PhD programs at the University Paris Sud since 1992.

Dr Salem Chouaib has authored over 350 publications and several reviews in the field of human immunology and tumor biology, as well as an editorship for contributions to several books. Furthermore, he is a guest lecturer at different universities.
He is adhoc referee for numerous journals and scientific foundations. He is a member of various professional associations and is a scientific advisor and consultant in many scientific institutions.